x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Determine the Efficacy of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma
Principal Investigator (?)
Study Number
F16004
Summary
To evaluate the use of SGX301, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell lymphoma (mycosis fungoides). 
Phase (?)
Phase III
Sponsor (?)
Contact

Daniel Ressler

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0